A single‐dose euglycaemic clamp study in two cohorts to compare the exposure of SAR341402 (insulin aspart) Mix 70/30 with US‐ and European‐approved versions of insulin aspart Mix 70/30 and SAR341402 rapid‐acting solution in subjects with type 1 diabetes

AIM: To compare the pharmacokinetic exposure of SAR341402 Mix 70/30 (SAR(Asp)‐Mix) with US‐ and European (EU)‐approved versions of insulin aspart Mix 70/30 (NovoLog Mix 70/30 [NN‐Mix‐US]/NovoMix 30 [NN‐Mix‐EU]) and SAR341402 insulin aspart solution (SAR‐Asp) in subjects with type 1 diabetes. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapitza, Christoph, Nosek, Leszek, Schmider, Wolfgang, Teichert, Lenore, Mukherjee, Bhaswati, Nowotny, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898688/
https://www.ncbi.nlm.nih.gov/pubmed/33236518
http://dx.doi.org/10.1111/dom.14260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898688/
https://www.ncbi.nlm.nih.gov/pubmed/33236518
http://dx.doi.org/10.1111/dom.14260

Ejemplares similares